A Two-compartment Dispersion Model Describes the Hepatic Outflow Profile of Diclofenac in the Presence of its Binding Protein
- 1 October 1991
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 43 (10) , 709-714
- https://doi.org/10.1111/j.2042-7158.1991.tb03463.x
Abstract
— The residence‐time distribution (RTD) of diclofenac in the rat single‐pass isolated perfused in‐situ liver (n = 4) was determined after bolus input into the hepatic portal vein. Addition of human serum albumin (5 g L−1) ensured extensive (>98%) binding of diclofenac within the perfusate. The one‐compartment form of the axial dispersion model of hepatic elimination, which assumes instantaneous radial distribution of substrate within the accessible spaces of the liver, failed to describe adequately the RTD of diclofenac. In contrast, the two‐compartment form of this model, which assumes that the radial transfer of unbound substrate between the vascular and cellular space is non‐instantaneous, provided an excellent description of the diclofenac data. Moreover, the mean (±s.d.) value for the hepatic dispersion number (DN) for diclofenac (0·354 ± 0·076) compared well with that determined for simultaneously injected [125I]human serum albumin (0·456 ± 0·078) using the one‐compartment dispersion model. These estimates of DN, a stochastic parameter which characterizes the axial spreading of individual elements during transit through the liver, were similar in magnitude to those reported for other tracers in the rat perfused liver. The findings suggest that common factors influenced the RTD of diclofenac and its binding protein, and indicate that the two‐compartment dispersion model may be a valuable tool for interpreting hepatic impulse‐response data for solutes whose hepatic distribution and elimination is influenced by membrane permeability.Keywords
Funding Information
- MRC (G8516637SA)
This publication has 20 references indexed in Scilit:
- Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholateJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Models of hepatic elimination: Comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic eliminationJournal of Pharmacokinetics and Biopharmaceutics, 1988
- On the relation between extended forms of the sinusoidal perfusion and of the convection-dispersion models of hepatic eliminationJournal of Theoretical Biology, 1987
- Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution methodJournal of Pharmacokinetics and Biopharmaceutics, 1987
- A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activityJournal of Pharmacokinetics and Biopharmaceutics, 1986
- A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerationsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Protein binding and hepatic clearance: Discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparationJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Protein binding and hepatic clearance: Studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparationJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Albumin helps mediate removal of taurocholate by rat liver.Journal of Clinical Investigation, 1981
- Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977